Streptococcus Pneumoniae

Infectious Disease

13 drugs in development·11 companies·1 clinical trial

Drug Pipeline by Phase

Approved(11)

Drug	Company
amoxicillin	Miromatrix Medical Inc. (MIRO)
cefepime	Seagen Inc. (SGEN)
cefepime	Atara Biotherapeutics, Inc. (ATRA)
ceftriaxone	Teva Pharmaceutical Industries Limited (TEVA)
ciprofloxacin	Altamira Therapeutics Ltd. (CYTOF)
ciprofloxacin	AMARIN CORP PLCUK (AMRN)
ciprofloxacin	ANI PHARMACEUTICALS INC (ANIP)
ciprofloxacin	Prestige Consumer Healthcare Inc. (PBH)
ciprofloxacin	SUNSET ISLAND GROUP (SUN)
ciprofloxacin	DR REDDYS LABORATORIES LTD (RDY)
clarithromycin	SUNSET ISLAND GROUP (SUN)

Phase 1(2)

Drug	Company
20-valent pneumococcal conjugate vaccine	PFIZER INC (PFE)
pg4 vaccine in buffer 2	PFIZER INC (PFE)

BioSniper tracks 13 drugs in development for Streptococcus Pneumoniae across 11 companies.

There are 1 clinical trial targeting Streptococcus Pneumoniae tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.